trending Market Intelligence /marketintelligence/en/news-insights/trending/KG4JQ909pYcDYSiV1eQsvg2 content esgSubNav
In This List

Seelos Therapeutics prices $6.7M offering of shares

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Seelos Therapeutics prices $6.7M offering of shares

Seelos Therapeutics Inc. priced an offering of common shares to raise $6.7 million in gross proceeds.

The New York-based pharmaceutical company, which is developing treatments for central nervous system disorders and other rare diseases, will sell 4,475,000 shares to certain institutional investors at $1.50 apiece to raise the amount.

Investors will also receive warrants to purchase up to 2,237,500 shares at $1.78 each.

The offering is expected to close by Aug. 27 and will help the company advance its product candidates which include SLS-004 for the treatment of Parkinson's.

Roth Capital Partners was the sole placement agent for the registered direct offering.